Objective: Patients with head and neck cancer undergoing surgery have a high incidence of postoperative complications. The aim of our study was to investigate whether postoperative nutrition of head and neck cancer patients using an arginineenhanced formula could improve nutritional variables as well as clinical outcomes. Design: Randomized clinical trial. Setting: Tertiary care. Subjects: A population of 90 patients with oral and laryngeal cancer was enrolled. Interventions: At surgery, patients were randomly allocated to two groups: (a) patients receiving an arginine-enhanced formula with arginine and fiber (group I) and (b) patients receiving an isocaloric, isonitrogenous formula with fiber enteral formula (group II). Results: No significant intergroup differences in the trend of the three plasma proteins (albumin, transferrin, prealbumin) and lymphocytes were detected. Gastrointestinal tolerance (diarrhea) was better in group II than I (40% group I and 13% group II: Po0.05). The postoperative complications due to infections were similar in both groups (4% group I and 9% group II: ns). Fistula (wound complication) was less frequent in the enriched nutrition group (5% group I and 11% group II: Po0.05); wound infection was similar in both groups. The length of postoperative stay was better in group I than II (25.8715 days vs 35724.6 days; Po0.05). Conclusions: In conclusion, arginine-enhanced formula improves fistula rates in postoperative head and neck cancer patients and decreases length of stay.
Introduction
Patients with head and neck cancer undergoing surgery have a high incidence of postoperative complications (anastomotic fistula, wound infections, and major complications such as septicemia) (Arriraga et al, 1990) and have several problems related to swallowing function and perception of dysphagia (Pauloski et al, 2002) .
It is known that the immune system is frequently affected in these patients. Also, surgery and malnutrition have been found to depress the immune system (Van Bokhorst-de van der Schueren et al, 1998) . The alterations in the host defense mechanism make patients susceptible to the above-mentioned complications. Although immune dysfunction could be multifactorial, this immune system may be modulated by specific nutritional substrates, such as arginine . There is evidence suggesting that enteral nutrition, supplemented with different agents, including arginine and dietary fiber, improve immune function and reduce postoperative complications in different groups of patients such as pancreatic surgery , surgery of stomach and colo-rectal cancer (Gianoti et al, 1999; Wu et al, 2001) , and critically ill patients (Caparros et al, 2001) . In a previously randomized clinical trial, our group has demonstrated a decrease in local complications of postsurgical patients with head and neck cancer (de Luis et al, 2002) . In this study, differences in formulas were arginine and dietary fiber, and perhaps fiber had a role in the detected differences.
The aim of our study was to investigate whether postoperative nutrition of head and neck cancer patients using an arginine-enhanced diet could improve nutritional variables as well as clinical outcomes, when compared with an isonitrogenous, isocaloric control enteral diet.
Materials and methods

Patients
A population of 90 patients with oral and laryngeal cancer was enrolled. Exclusion criteria included: severely impaired hepatic function (total bilirubin concentration 43.5 mg/dl) and renal function (serum creatinine concentration 42.5 mg/dl), ongoing infections, autoimmune disorders, steroids treatment, nutritional oral supplementation in previous 6 months, and severely malnourished (weight loss o10% of body weight). The study was a prospective 
Nutrition
At surgery, patients were randomly allocated to two groups: (a) patients receiving an enteral diet supplement with arginine and dietary fiber (group I) and (b) patients receiving an isocaloric, isonitrogenous enteral formula with dietary fiber (group II). Table 1 shows the composition of the two enteral diets. Enteral feeding was started within 12 h of surgery at a rate of 20 ml/h, via an intraoperatively placed nasogastric tube. The infusion rate was progressively increased every 24 h until the daily nutritional goal (32 total kcal/kg; 1.7 g protein/kg) was reached, on postoperative day 4. All patients reached 100% of the calculated requirements. No dropouts were present in the study. The end point to discontinuing nutritional support was a minimum oral intake of 1500 cal day and 1 g/kg/day of protein without supplementation with a minimum of 10 days of enteral support.
In all patients, prophylactic antibiotic treatment was given for 7 days postoperatively (ceftazidime, 500 mg tid i.v. and clyndamicine 300 mg tid i.v.).
Patient monitoring
Perioperatively and on postoperative day 14 the following parameters were evaluated: serum values of prealbumin (mg/ dl), transferrin (mg/dl), albumin (g/dl), and total number of lymphocytes (10 6 /ml). Postoperative complications were recorded as none, general infections (respiratory tract infection was diagnosed when the chest radiographic examination showed new or progressive unfiltration, temperature above 38.51C and isolation of pathogens from the sputum or blood culture and/or urinary tract infection was diagnosed if the urine culture showed at least 10 5 colonies of a pathogen), and wound complications such as fistula and/or wound infection. All complications were assessed with standard methods by the same investigator. Gastrointestinal problems related to enteral feeding were also recorded (diarrhea, 45 liquid stools in a 24-h period or an estimated volume 42000 ml/day).
Assays
Fasting blood samples were drawn for measurement of albumin (3. 5-4.5 g/dl), prealbumin (18-28 mg/dl), and transferrin (250-350 mg/dl) with an autoanalyzer (Hitachi, ATM, Mannheim, Germany). Lymphocytes (1.2-3.5 Â 10 3 /ml) were analyzed with an analyzer (Beckman Coulter, Inc, LA, CA, USA).
Statistical analysis
The sample size was calculated to decrease 20% of fistula complication with 90% power and 5% significance. The results were expressed as average7s.d. The distribution of variables was analyzed using the Kolmogorov-Smirnov test. Quantitative variables with normal distribution were analyzed with two-tailed paired or unpaired Student's t-test. Nonparametric variables were analyzed with the Friedman and Wilcoxon tests. To minimize the potential for introducing bias, all randomized patients were included in the comparisons, irrespective of whether or not and for how long they complied with their allocated regimen (intentionto-treat analysis). A P-value below 0.05 was considered statistically significant. 
Results
In all, 90 patients were enrolled in the study. The mean age was 60.5712.3 y (six females/84 males). There were 45 patients in group I (arginine-enhanced diet) and 45 patients in control diet group II. The characteristics of the patients on enrollment were similar for the two groups, reflecting the homogeneity of the patient. There were no significant differences with respect to gender, mean age, body weight, location, and stage of tumor (Table 2) . Patients had the same % preoperatively weight loss (group I 2.5 vs 1.4% group II: ns). Totally, 43 patients underwent resection of a tumor located in the oral cavity with unilateral or bilateral neck dissection; 47 patients underwent laryngectomy (total or partial) or pharyngo-laryngectomy, with the same distributions of surgery in groups I and II. The duration of enteral nutrition in both groups was similar with an average duration of 21710 days.
As shown in Table 3 , no significant intergroup differences in the trend of the three plasma proteins and lymphocytes were detected. No differences were detected in weight.
Gastrointestinal tolerance (diarrhea) of both formulas was higher in group I (40% group I and 13% group II: Po0.05). There were no dropouts due to intolerance.
The postoperative infections complications (urinary tract and pneumonia with similar distribution) were similar in both groups (4% group I and 9% group II: ns). Statistical differences were detected in local complications, fistula diagnosed by X-ray was less frequent in arginine-enhanced group (5% group I and 11% group II: Po0.05), and wound infection was similar in both groups (0% group I and 0% group II: ns).
The length of postoperative stay was 25.8 þ 15 days in the arginine-enhanced group and 35724.6 days in the control group (Po0.05) ( Table 4) .
Discussion
Malnutrition and immunosuppression were two characteristics of head and neck cancer patients (Riboli et al, 1996) ; malnutrition is reported in 50% of these patients (Bassett and Dobie, 1990) . Immunosuppression is related to surgery and immunosuppressive capacity of the tumor (Katz, 1983) . For example, Van Bokhorst-de van der Schueren has recently reported that patients (head and neck cancer) with weight loss exceeding 10% during the 6 months before surgery are at great risk of the occurrence of major complications (Van Bokhorst-de van der Schueren et al, 1997).
Few studies have analyzed the immunonutrition formula with arginine or dietary fiber used in our study. Riso et al (2000) confirmed that an enteral diet supplemented with arginine in the early postoperative period improved postoperative immunological status and speeds up recovery from the immunodepression following surgical trauma. In malnourished patients subgroup of this study, administration of an enriched formula reduced major postoperative complications and length of postoperative stay significantly. In our previous study (De Luis et al, 2002) , the length of stay was similar in both groups; however, wound complications (fistula) were improved. Snyderman et al's (1999) formula with a perioperative nutritional supplementation with an immune-enhancing formula was superior to the standard formula in the prevention of postoperative infectious complications. There was no significant difference in terms of wound-healing problems or the duration of hospitalization. Higher serum of albumin was demonstrated in the enriched formula group compared with the standard formula. Caparros et al (2001) showed in critically ill patients with a diet enriched with arginine and fiber a decrease in catheter-related sepsis rate. In our study with better nourished patients than reported in previous studies, no differences were detected in postoperative infections and complications, but wound complications were lower and plasma proteins improved with standard and immuneenhancing formula without differences. The length of stay was better in patients using arginine-enhanced formula than control formula, as previously reported by Riso et al. In another study, the arginine-supplemented formula (Van Bokhorst-de van der Schueren et al, 2001) did not significantly improve nutritional status, reduce the immune suppression, or affect clinical outcome in head and neck cancer patients, however, only 9 days of postoperative tube feeding was used in this study, and our patients received an average of 21 days of enteral nutrition. Arginine stimulates anabolic hormone release, improves survival in gut-derived sepsis and peritonitis by modulating bacterial clearance, and accelerates wound healing . In our previous study (De Luis et al, 2002) ,two formulas were different in terms of arginine and fiber. Fibersupplemented enteral formulas may have a beneficial effect on components of the gut barrier, as well as the gut mucosa, and on bacterial translocation (Cummings, 1983) . Soluble fibers are degraded by anaerobic colonic flora forming shortchain fatty acids, with a trophic effect on the mucosa of large bowel and metabolic effects on the liver. In our study, only arginine was the difference between formulas with the same amount of fiber. Secondary to this fact, arginine could be the key in our study.
In conclusion, arginine-enhanced formula improves fistula rates in postoperative head and neck cancer patients and decreases the length of stay.
